Our findings were: (1) There was no statistical significance between LM, LAD, LCX, or RCA involvement in patients with STEMI and SARS-CoV-2 versus without SARS-CoV-2; (2) There was a numerical trend toward LAD disease involvement in patients with STEMI and SARS-CoV-2 versus without SARS-CoV-2 (49.6% vs 44.9%); (3) Higher in-hospital mortality of statistical significance was observed in patients with STEMI and SARS-CoV-2 versus without SARS-CoV-2 (22.1% vs 5.8%, OR 5.24; 95% Confidence Interval 3.63, 7.56).
← all excerpts
Comparison of Coronary Artery Involvement and Mortality in STEMI Patients With and Without SARS-CoV-2 During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.
1
—
—